Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Somsak, Laptikultham"'
Publikováno v:
Circulation. 137
Introduction: There is little evidence to describe risk factors for dementia in a Thai general population. Hypothesis: This study was aimed to examine factors associated with the risk of developing dementia in a Thai general population in Ubon Ratcha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ec6766e05e7d9b7905d7c3aeb7c53e4f
https://doi.org/10.1161/circ.137.suppl_1.p016
https://doi.org/10.1161/circ.137.suppl_1.p016
Autor:
Somsak Laptikultham, Somchai Towanabut, Charungthai Dejthevaporn, Poonsri Rangseekajee, Kongkiat Kulkantrakorn, Panas Tanyakitpisal, Kritsada Rodprasert, Sunsanee Pongpakdee, Suwanna Setthawatcharawanich, Bandit Thinkhamrop
Publikováno v:
Psychogeriatrics. 13:1-8
Background: Rivastigmine is a cholinesterase inhibitor for treatment of mild to moderate Alzheimer's disease (AD) and dementia associated with Parkinson's disease. The new patch formulation was recently made available. We assessed the safety, tolerab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12605e8aa59673990b4cf6d69b106ebb
https://doi.org/10.1111/j.1479-8301.2012.00403.x
https://doi.org/10.1111/j.1479-8301.2012.00403.x
Autor:
Kongkiat, Kulkantrakorn, Panas, Tanyakitpisal, Somchai, Towanabut, Charungthai, Dejthevaporn, Poonsri, Rangseekajee, Sunsanee, Pongpakdee, Somsak, Laptikultham, Kritsada, Rodprasert, Suwanna, Setthawatcharawanich, Bandit, Thinkhamrop
Publikováno v:
Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society. 13(1)
Rivastigmine is a cholinesterase inhibitor for treatment of mild to moderate Alzheimer's disease (AD) and dementia associated with Parkinson's disease. The new patch formulation was recently made available. We assessed the safety, tolerability, and c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::594421ee07e0527a9e3a26ea63b920cd
https://pubmed.ncbi.nlm.nih.gov/23551405
https://pubmed.ncbi.nlm.nih.gov/23551405
Autor:
Jithanorm, Suwantamee, Samart, Nidhinandana, Suwat, Srisuwananukorn, Somsak, Laptikultham, Apichart, Pisarnpong, Siwaporn, Chankrachang, Adul, Bundhukul
Publikováno v:
Journal of the Medical Association of Thailand = Chotmaihet thangphaet. 87(11)
Piribedil is a non-ergot D2/D3 dopamine agonist with antagonistic effect on alpha2-adrenoceptors and lack of agonist properties at 5-HT2A/2C receptors. Previous studies indicated its efficacy in monotherapy as well as in combinatio' s disease in L-do
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c76befa86ae20ca96961ec22fbefdc04
https://pubmed.ncbi.nlm.nih.gov/15825702
https://pubmed.ncbi.nlm.nih.gov/15825702
Autor:
Olsen, Sonja J.1,2 solsen@cdc.gov, Campbell, Angela P.2, Supawat, Krongkaew3, Liamsuwan, Sahas4, Chotpitayasunondh, Tawee4, Laptikulthum, Somsak5, Viriyavejakul, Akravudh6, Tantirittisak, Tasanee6, Tunlayadechanont, Supoch7, Visudtibhan, Anannit7, Vasiknanonte, Punnee8, Janjindamai, Supachai8, Boonluksiri, Pairoj9, Rajborirug, Kiatsak9, Watanaveeradej, Veerachai10, Khetsuriani, Nino2, Dowell, Scott F.1,2, Thailand Encephalitis Surveillance Team (CORPORATE AUTHOR)
Publikováno v:
Emerging Infectious Diseases. Feb2015, p280-289. 10p. 1 Diagram, 3 Charts, 1 Graph.